Thermo Fisher price target raised to $670 from $613 at Morgan Stanley

Morgan Stanley analyst Tejas Savant raised the firm’s price target on Thermo Fisher to $670 from $613 and keeps an Overweight rating on the shares following the company’s "solid" top and bottom line beat in Q4 and initial FY23 outlook that topped the Street view. The 7% core growth outlook is "solid" and "sufficient to calm investor nerves," said the analyst, who reiterates Thermo Fisher as a top pick.